Fate Therapeutics FATE
NASDAQ FATE
$2.32 +0.02 (+0.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Cash from Investing Activities (2012 - 2026)

Updated

Fate Therapeutics (FATE) posted Cash from Investing Activities of $14.56 million for Q2 2026, down 25.7% from $19.59 million a year earlier and down 38.3% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Cash from Investing Activities (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Investing Activities at Fate Therapeutics was $87.05 million, down 21.3% year-over-year; for FY2025, it was $111.17 million, up 809.9% from FY2024.

  • In prior years, Fate Therapeutics' Cash from Investing Activities was $12.22 million in FY2024 (-89.2%), $112.67 million in FY2023 (-32.4%), $166.75 million in FY2022 and -$324.02 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Cash from Investing Activities since Q2 2024.
  • On a year-over-year basis, Cash from Investing Activities increased in three of the last seven quarters, with growth averaging 4.8%.
  • The strongest year-over-year quarter for Cash from Investing Activities in the past five years was Q1 2025, with growth of 146.5%; the weakest was Q3 2023, with a decline of 69.1%.
  • According to Business Quant data, Cash from Investing Activities for the three prior quarters was $23.59 million (Q1 2026), $27.63 million (Q4 2025) and $21.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Fate Therapeutics 270.73 Mn 270.73 Mn - 14.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.56 Mn
Mar 31, 2026 23.59 Mn
Dec 31, 2025 27.63 Mn
Sep 30, 2025 21.27 Mn
Jun 30, 2025 19.59 Mn
Mar 31, 2025 42.67 Mn
Dec 31, 2024 22.82 Mn
Sep 30, 2024 25.46 Mn
Jun 30, 2024 -53.37 Mn
Mar 31, 2024 17.31 Mn
Dec 31, 2023 45.35 Mn
Sep 30, 2023 24.81 Mn
Jun 30, 2023 33.17 Mn
Mar 31, 2023 9.34 Mn
Dec 31, 2022 53.11 Mn
Sep 30, 2022 80.38 Mn
Jun 30, 2022 40.29 Mn
Mar 31, 2022 -7.03 Mn
Dec 31, 2021 71.28 Mn
Sep 30, 2021 77.96 Mn
API Access

Fate Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=FATE&period=max&api_key=YOUR_API_KEY